News | August 06, 2024
UK Relonchem receives marketing authorization for Levonorgestrel 1.5 mg Tablets
Relonchem Limited has received Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets from UK MHRA
Relonchem Limited has received Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets from UK MHRA
Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
Ephedrine Sulfate injection USP, 50 mg/mL is indicated for the treatment of clinically important hypotension
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
The Unit has been issued GMP Certification from ANVISA-Brazil
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Shares and American Depositary Shares of Olink for $26.00 per Share
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
Subscribe To Our Newsletter & Stay Updated
